Medicare Part D Overutilization Monitoring System
Guidance for updates to the OMS effective January 31, 2014 which include functionality is being added to allow sponsors to report internally-identified potential opioid overutilization issues that have not been identified by CMS, for each beneficiary-issue ticket, prior contract IDs will be shown in applicable reports if prescription drug event (PDE) data from previous contracts of enrollment contributed to the beneficiary’s potential overutilization during the measurement period, the response processing logic for certain overutilization issue response codes is being revised and a new response code, CDO, will be available.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 17, 2014
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.